Equity Gap - Early Stage Investment

Investing in Emerging Businesses throughout Scotland

newS - ENTEROBIOTIX

 

Insider (Sep 2018) - Biopharm start-up EnteroBiotix appoints new CEO as it is granted MHRA Licence

Aberdeen biopharmaceutical start-up EnteroBiotix has appointed a new chief executive officer as it progresses towards commercialisation of its products.

Senior biotechnology executive Dr James Clark becomes CEO, with founder Dr James McIlroy moving to the role of chief business officer.


Scottish Business News (June 2018) - EnteroBiotix launches groundbreaking facility

First Minister Nicola Sturgeon and Chief Medical Officer Catherine Calderwood visited highly rated biopharmaceutical startup EnteroBiotix yesterday at its groundbreaking facility at the Aberdeen Blood Transfusion Centre on the Foresterhill Health Campus as the company progresses towards the commercialisation of its products and a fresh round of external funding that will see the business through its next phase of growth.

The Scotsman (June 2017) -£500k cash injection for Aberdeen biotech firm EnteroBiotix

A biotechnology company focused on using the body’s own micro-organisms to prevent and treat disease has raised £500,000 in funding. The financing into Aberdeen-based EnteroBiotix was led by Equity Gap and supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise.

 

 

 


 

 

 

Back to
Main News page

 

 

 

 

  • Scottish Enterprise
  • LINC Scotland
  • LinkedIN
  • Twitter Link

 

© 2018 Equity Gap, Edinburgh Scotland Email: info@equitygap.co.uk.

Membership Rules | Contact Us

 


Design by Richard Pavey ~ Web Design & Development